Is lamivudine effective on precore/core promoter mutants of hepatitis B virus?
Zoulim
F
F
Trépo
C
C
D000998:Antiviral Agents / Q000627:therapeutic use*; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D009154:Mutation / Q000187:drug effects*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014758:Viral Core Proteins / Q000235:genetics*
D000998:Antiviral Agents; D014758:Viral Core Proteins; D019259:Lamivudine